Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

ASHLAND A local family physician and former Ashland School Board member pleaded guilty on Tuesday to federal charges related to the unlawful distribution of weight loss drugs on the heels of his ...

The increase in weight loss ... week time point in its pivotal trial. Martin Holst Lange, Novo Nordisk's head of development, said that the safety and tolerability of the two doses of semaglutide ...

Injectable drugs require refrigeration when they are stored or transported, and the pill potentially opens up the market ...

People are ‘microdosing’ weight-loss drugs like Ozempic. A GP explains the risks - Millions of people worldwide are now using ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Have you, or a loved one, thought of taking one of the new weight ... time (as demonstrated by the story of Dr Pawel Gadomski in yesterday's Mail – he's maintained his 10st (63.5kg) weight loss ...

Shares of Novo Nordisk, Eli Lilly, Structure Therapeutics and Viking Therapeutics gain as PFE abandons development of its ...

Specifically, GLP-1R agonists like exendin-4, liraglutide, and semaglutide have been found to decrease alcohol ... abnormal behaviours, poor health, or weight loss exceeding 15%. Technical ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...